PETX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds
Investors of a Class Action Involving Aratana Therapeutics, Inc. and a
Lead Plaintiff Deadline of April 7, 2017

March 08, 2017 10:55 AM Eastern Daylight Time

NEW YORK--(EON: Enhanced Online News)--The Law Offices of Vincent Wong announce that a class action lawsuit has
been commenced in the USDC for the Southern District of New York on
behalf of investors who purchased Aratana Therapeutics, Inc.
(NASDAQ:PETX) securities between March 16, 2015 and February 3, 2017.

According to the complaint, throughout the Class Period Defendants made
false and/or misleading statements and/or failed to disclose that: (1)
Aratana did not have manufacturing contracts in place sufficient to
support manufacturing of ENTYCE at a commercial scale; (2) therefore,
ENTYCE was not likely to be commercially available until late 2017; (3)
accordingly, Aratana had misled investors regarding the probable
timeline for a commercial launch of ENTYCE; and (4) consequently,
Aratana’s public statements were materially false and misleading at all
relevant times.

If you suffered a loss in Aratana you have until April 7, 2017 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn’t require that you serve as a lead
plaintiff. To obtain additional information, contact Vincent Wong, Esq.
either via email vw@wongesq.com, by
telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/aratana-therapeutics.

Vincent Wong, Esq. is an experienced attorney that has represented
investors in securities litigations involving financial fraud and
violations of shareholder rights. Attorney advertising. Prior results do
not guarantee similar outcomes.